Author

Ivan Castello-Serrano

Istituto Nazionale Genetica MolecolareORCID 0000-0002-2307-6476Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Abeer MahfoudiD· 1 shared Alessio Nicola FerraroiD· 1 shared Alice RandoniD· 1 shared Edoardo ScarpaiD· 1 shared Elena PincaiD· 1 shared Giorgia MoschettiiD· 1 shared Guido PapaiD· 1 shared Loris RizzelloiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abeer MahfoudORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A vesicle-based platform for high-efficiency, high-viability CRISPR/Cas9 knockout in primary human myeloid cells

Silvia Fiori, Maira Russo, Alice Randon, Alessio Nicola Ferraro, Tiziana Julia Nadjeschda Schmidt, Elena Pinca, Rana Kamel Mohamed Ali Elnady, Ivan Castello-Serrano, Paola Capasso, Abeer Mahfoud, Giorgia Moschetti, Edoardo Scarpa, Loris Rizzello, Niklas Arndt Schmacke, Veit Hornung, , Manuel Albanese

This paper develops a vesicle-based CRISPR/Cas9 platform for efficient gene knockout in primary human myeloid cells, preserving viability and enabling downstream functional studies.

bioRxiv · Aug 3, 2026 · PreprintImmunology